FHL-5 Activators
FHL-5 Activators encompass a spectrum of chemical compounds that indirectly augment the functional activity of FHL-5 via diverse signaling pathways and biological processes. Forskolin and IBMX, through their ability to elevate intracellular cAMP levels, activate protein kinase A (PKA), which can phosphorylate a range of substrates. This phosphorylation can enhance FHL-5's functional activity by promoting its coactivator functions within transcriptional complexes, bolstering gene expression regulation. Similarly, Sphingosine-1-phosphate, by activating G protein-coupled receptors, initiates a cascade of signaling events that could facilitate the coactivation roles of FHL-5 by influencing transcriptional regulation. PMA, as a PKC activator, and LY294002's inhibition of PI3K potentially shift the cellular signaling balance, indirectly promoting FHL-5's role in gene expression without affecting its own expression levels.
FurtherFHL-5 Activators encompass a spectrum of chemical compounds that indirectly augment the functional activity of FHL-5 via diverse signaling pathways and biological processes. Forskolin and IBMX, through their ability to elevate intracellular cAMP levels, activate protein kinase A (PKA), which can phosphorylate a range of substrates. This phosphorylation can enhance FHL-5's functional activity by promoting its coactivator functions within transcriptional complexes, bolstering gene expression regulation. Similarly, Sphingosine-1-phosphate, by activating G protein-coupled receptors, initiates a cascade of signaling events that could facilitate the coactivation roles of FHL-5 by influencing transcriptional regulation. PMA, as a PKC activator, and LY294002's inhibition of PI3K potentially shift the cellular signaling balance, indirectly promoting FHL-5's role in gene expression without affecting its own expression levels.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by increasing cAMP levels, activates PKA which can then phosphorylate specific substrates that may enhance the functional activity of FHL-5 by promoting its coactivator functions within the cell. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a nonspecific inhibitor of phosphodiesterases, raises intracellular cAMP levels, potentially augmenting the pathways in which FHL-5 is involved by fostering its interaction with other nuclear proteins. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates G protein-coupled receptors, inducing signaling cascades that could enhance FHL-5 activity by modulating its role in nuclear transcriptional regulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC) which is involved in various signaling pathways; it could enhance FHL-5 activity by altering its phosphorylation state, thus influencing its coactivator interactions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, may shift cellular signaling in a way that indirectly promotes FHL-5's functional activities by affecting its participation in transcriptional regulation of specific genes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, by inhibiting MEK, could lead to alterations in the MAPK/ERK pathway, potentially enhancing the functional activity of FHL-5 through its effects on cellular transcription processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, may indirectly activate FHL-5 by modulating stress response pathways, potentially enhancing its involvement in cellular homeostasis and transcriptional regulation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK, which can alter the cytoskeleton and cellular tension, potentially enhancing FHL-5's role in mechanotransduction and its associated transcriptional regulatory activities. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, potentially enhancing FHL-5 activity by influencing calcium-dependent transcription factors and coactivators with which FHL-5 may interact. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor that could enhance FHL-5 activity by promoting a more open chromatin structure, thus facilitating its role in transcriptional coactivation. | ||||||